Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials

Yasuhisa Fujii is an Editorial Board member of the International Journal of Urology and a co-author of this article. To minimize bias, he was excluded from all editorial decision-making related to the acceptance of this article for publication. The other authors declare no conflicts of interest.